The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EHA 2016 | The research activities of the European Research Initiative on CLL (ERIC)
Paolo Ghia, MD, PhD from the San Raffaele Scientific Institute, Milan, Italy discusses the research activities of the European Research Initiative on CLL (ERIC), which held a General Assembly at the European Hematology Association (EHA) 2016 Annual Congress in Copenhagen, Denmark. Dr Ghia mentions a study that is collecting data on chronic lymphocytic leukemia (CLL) patients treated with bendamustine plus rituximab in second line. He also discusses the creation of a data set of CLL patients in Europe called Minimum Data Set Project, with the aim to map the number of patients in Europe.
